Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
ATP-independent protease that degrades mitochondrial transit peptides following their cleavage. It also degrades other unstructured peptides.
KEGG: ncr:NCU01272
Mitochondrial presequence protease (cym-1) is an ATP-independent protease belonging to the peptidase M16 family, PreP subfamily. It is a 1012 amino acid protein with a molecular mass of 112.825 kDa in Neurospora crassa. The primary function of cym-1 is to degrade mitochondrial transit peptides after they are cleaved during protein import into mitochondria. Additionally, it has the capacity to degrade other unstructured peptides within the mitochondrial environment .
Cym-1 belongs to the peptidase M16 family, PreP subfamily. The full protein sequence consists of 1012 amino acids and contains specific functional domains that contribute to its proteolytic activity. The structural features allow it to recognize and degrade unstructured peptides, particularly mitochondrial transit peptides that remain after the import process . The specific functional domains include regions responsible for substrate recognition and the catalytic site necessary for peptide bond hydrolysis.
Cym-1 is distinguished from other proteases in Neurospora crassa by its ATP-independent mechanism of action and its specificity for mitochondrial transit peptides and unstructured peptides. Unlike some other proteases that require energy input in the form of ATP hydrolysis, cym-1 can function without this energy source. Its localization to mitochondria and its specialized role in post-import processing further differentiate it from generalized proteases in the cytosol or other cellular compartments.
For recombinant expression of cym-1, researchers should consider several expression systems based on the specific research objectives. For structural and functional studies, E. coli expression systems can be utilized with appropriate optimization of codons and expression conditions. For studies requiring post-translational modifications, eukaryotic systems such as CHO-K1 cells may be preferable, similar to the approach used for recombinant MUC1 fusion proteins . When designing expression constructs, particular attention should be paid to:
Codon optimization for the chosen expression host
Inclusion of appropriate purification tags (His, GST, or MBP)
Consideration of solubility enhancers if expression yields are low
Purification of recombinant cym-1 can be challenging due to its size (112.825 kDa) and potential for aggregation. A multi-step purification protocol is recommended:
Initial capture using affinity chromatography (Ni-NTA for His-tagged constructs)
Intermediate purification via ion exchange chromatography
Final polishing using size exclusion chromatography
For optimal results, inclusion of protease inhibitors during cell lysis and early purification steps is critical to prevent degradation. Additionally, maintaining reducing conditions throughout purification helps prevent disulfide bond formation and protein aggregation.
Based on principles applied to other recombinant protein productions, researchers can optimize functional cym-1 yield through systematic evaluation of expression parameters. Drawing from the bioprocess development approaches used for recombinant proteins in CHO-K1 cells , the following parameters should be optimized:
| Parameter | Range to test | Expected impact |
|---|---|---|
| pH | 6.8-7.2 | Influences protein stability and solubility |
| Temperature | 16-30°C | Lower temperatures may improve folding |
| Induction timing | Early to late log phase | Affects cellular resources for protein production |
| Media composition | Minimal to enriched | Provides necessary nutrients for growth and expression |
| pO₂ | 20-60% of air saturation | Affects oxidative phosphorylation and productivity |
Monitoring oxygen uptake rate (OUR) during cultivation can serve as an indicator of metabolic activity and potential productivity, as demonstrated in other recombinant protein production systems .
To assess the proteolytic activity of recombinant cym-1, researchers should develop assays that monitor the degradation of model substrates. Recommended approaches include:
Fluorogenic peptide substrates with quencher-fluorophore pairs that increase fluorescence upon cleavage
SDS-PAGE analysis of substrate degradation over time
Mass spectrometry-based methods to identify cleavage sites and kinetics
Activity assays should be performed under physiologically relevant conditions, particularly regarding pH (mitochondrial pH ≈ 8.0) and redox status. Control experiments should include heat-inactivated enzyme and reactions with known protease inhibitors to confirm specificity.
Investigating the substrate specificity of cym-1 requires a systematic approach to identify the sequence and structural features that make peptides suitable substrates. Recommended methodologies include:
Peptide library screening to identify preferred sequence motifs
Site-directed mutagenesis of putative substrates to identify critical residues
Structural analysis of enzyme-substrate complexes using techniques such as X-ray crystallography or cryo-EM
When designing experiments, researchers should consider both the primary sequence and secondary structure elements that may influence recognition and processing by cym-1.
To study the interactions between cym-1 and its binding partners, multiple complementary techniques should be employed:
Co-immunoprecipitation followed by mass spectrometry for identification of novel interactors
Surface plasmon resonance (SPR) or bio-layer interferometry (BLI) for quantitative binding kinetics
Yeast two-hybrid screening for detecting protein-protein interactions
Proximity labeling approaches (BioID, APEX) to identify transient or weak interactions
When studying interactions within the mitochondrial environment, special consideration should be given to the physiological conditions of this compartment, including pH, ion concentrations, and redox state.
Based on patterns observed with other N. crassa proteins, cym-1 expression likely varies across different nutritional and environmental conditions. Drawing from the methodologies used to study NcSpds and NcSr expression correlation , researchers should:
Utilize RNA-Seq data from diverse conditions to identify expression patterns
Calculate RPKM values across different datasets to normalize expression levels
Perform correlation analyses to identify genes with similar expression patterns
Confirm expression changes using RT-qPCR under controlled conditions
The expression analysis should encompass various nutritional resources (such as different carbon sources), developmental stages, stress conditions, and genetic backgrounds to comprehensively understand cym-1 regulation .
To study the transcriptional regulation of cym-1, researchers should employ a multi-faceted approach:
Promoter analysis through bioinformatics to identify potential regulatory elements
Chromatin immunoprecipitation (ChIP) to identify transcription factors binding to the cym-1 promoter
Reporter gene assays using the cym-1 promoter to study regulation under different conditions
CRISPR-based approaches to edit regulatory elements and assess their function
Following the approach used for analyzing other N. crassa genes, researchers should analyze multiple RNA-Seq datasets from different experimental conditions to identify patterns in cym-1 expression that might indicate specific regulatory mechanisms .
Creating and validating cym-1 knockout strains requires a systematic approach:
Design of targeting constructs with appropriate selectable markers
Transformation of N. crassa using established protocols
Screening of transformants using PCR to identify successful integration events
Confirmation of gene deletion using both genomic PCR and Western blotting
Phenotypic characterization under various growth conditions
For functional complementation studies, researchers should consider the mutagenesis approaches used for other N. crassa proteins, such as the site-directed mutagenesis strategies employed for CDT-1 and CDT-2 .
To study the relationship between mitochondrial dysfunction and cym-1, researchers should:
Induce mitochondrial stress using chemical inhibitors of respiratory complexes
Monitor changes in cym-1 expression at both mRNA and protein levels
Assess alterations in proteolytic activity under different stress conditions
Compare wild-type responses to those in strains with compromised mitochondrial function
This approach can reveal whether cym-1 plays a role in the mitochondrial stress response and how its function may be regulated during mitochondrial dysfunction.
Studying the evolutionary conservation of cym-1 requires comparative genomics and functional analyses:
Identify homologs across diverse fungal species through sequence analysis
Compare sequence conservation in key functional domains
Express homologs from different species in a common host for functional comparison
Perform complementation studies in cym-1 deletion strains
This comparative approach can provide insights into the evolution of mitochondrial presequence processing mechanisms and potentially identify species-specific adaptations.
Structural biology techniques can provide critical insights into cym-1 function:
X-ray crystallography or cryo-EM to determine the three-dimensional structure
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to identify dynamic regions
Molecular dynamics simulations to study conformational changes during substrate binding
Structure-guided mutagenesis to test functional hypotheses
These structural insights can guide the development of specific inhibitors or activators and help elucidate the molecular basis of substrate recognition.
Common challenges in recombinant cym-1 production include:
| Challenge | Potential solutions |
|---|---|
| Low expression levels | Optimize codon usage, try different promoters, or use specialized expression strains |
| Protein insolubility | Express as fusion with solubility tags (MBP, SUMO), lower induction temperature, or include stabilizing additives |
| Proteolytic degradation | Include protease inhibitors, express in protease-deficient strains, or optimize purification speed |
| Loss of activity | Ensure proper folding conditions, include cofactors if needed, or optimize buffer composition |
| Aggregation during storage | Add stabilizing agents, optimize buffer conditions, or store as aliquots to avoid freeze-thaw cycles |
Each of these challenges requires systematic testing of conditions to identify optimal parameters for the specific construct being used.
Validation of purified recombinant cym-1 functionality should include:
Size and purity assessment via SDS-PAGE and Western blotting
Mass spectrometry confirmation of protein identity
Circular dichroism to assess secondary structure integrity
Activity assays using model substrates under physiological conditions
Thermal stability assessment using differential scanning fluorimetry
These combined approaches provide assurance that the purified protein retains its native structure and enzymatic function.
Essential controls for cym-1 experiments include:
Heat-inactivated enzyme to differentiate enzymatic activity from non-specific effects
Catalytically inactive mutants (typically generated by mutating active site residues)
Substrate-only controls to assess spontaneous degradation
Known protease inhibitors to confirm specificity of observed activity
Time-course measurements to establish reaction kinetics
Additionally, when performing expression studies, appropriate housekeeping genes should be included for normalization, particularly when comparing across different conditions or strains .
Investigation of cym-1's role in mitochondrial quality control should focus on:
Interaction with components of mitochondrial protein import machinery
Potential role in degrading misfolded or damaged proteins within mitochondria
Coordination with other quality control systems (e.g., mitophagy, proteasomal degradation)
Response to mitochondrial stress conditions and involvement in stress signaling
This research direction could reveal previously unappreciated functions of cym-1 beyond its established role in transit peptide degradation.
Emerging technologies with potential to advance cym-1 research include:
CRISPR-based genome editing for precise manipulation of the cym-1 gene
Single-cell transcriptomics to reveal cell-to-cell variation in cym-1 expression
Cryo-electron tomography to visualize cym-1 in its native mitochondrial environment
Proximity labeling approaches to map the cym-1 interaction network in vivo
Advanced mass spectrometry techniques to identify the complete repertoire of cym-1 substrates
Application of these technologies could provide unprecedented insights into cym-1 function and regulation.
Exploring cym-1 as a model for understanding homologous proteases in higher eukaryotes requires:
Comparative analysis of cym-1 with mammalian mitochondrial proteases
Heterologous expression studies to assess functional conservation
Investigation of disease-associated mutations in homologous proteins
Development of model systems to study conserved functions
This translational approach could establish connections between fungal mitochondrial proteases and human health, potentially identifying novel therapeutic targets for mitochondrial disorders.